1. Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom;
2. Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom;
3. Sunderland Royal Hospital, South Tyneside and Sunderland National Health Service Foundation Trust, Sunderland, United Kingdom;
4. Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom;
5. Department of Critical Care, Manchester Royal Infirmary, Manchester, United Kingdom;
6. Acute Intensive Care Unit, Wythenshawe Hospital, Manchester, United Kingdom;
7. University College Hospital London, London, United Kingdom;
8. Northern Ireland Clinical Trials Unit, Belfast, United Kingdom;
9. Royal College of Surgeons in Ireland, Dublin, Ireland;
10. University Hospital Southampton, Southampton, United Kingdom;
11. National Institute for Health and Care Research Southampton Biomedical Research Centre, University of Southampton, Southampton, United Kingdom;
12. King’s Trauma Centre, King’s College Hospital, London, United Kingdom;
13. Department of Critical Care, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom;
14. Regenerative Medicine Institute at CÚRAM Centre for Research in Medical Devices, University of Galway, Galway, Ireland;
15. Department of Critical Care, Belfast Health and Social Care Trust, Belfast, United Kingdom;
16. Critical Care Unit, University Hospitals Birmingham, Birmingham, United Kingdom;
17. Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom;
18. National Health Service Blood and Transplant, Oxford, United Kingdom;
19. National Health Service Blood and Transplant, Birmingham, United Kingdom;
20. Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom;
21. Intensive Care Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom;
22. Institute of Life Course Medical Sciences, University of Liverpool, Liverpool Centre for Cardiovascular Science, Liverpool, United Kingdom;
23. Centro de Investigación Biomédica en Red–Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain;
24. Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain;
25. Unidad de Cuidados Intensivos Cardiológicos, Hospital Universitario Central de Asturias, Oviedo, Spain;
26. Departamento de Biología Funcional, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain; and
27. Independent Patient and Public Representative, Sherborne, United Kingdom